Zhongchao (ZCMD) Total Non-Current Liabilities (2021 - 2022)
Zhongchao (ZCMD) reported Total Non-Current Liabilities of -$31.6 million for Q4 2022, up 3.0% year-over-year from -$30.7 million in Q4 2021, and up 3.0% on a QoQ basis from -$32.6 million in Q4 2021.
Zhongchao (ZCMD) has 2 years of Total Non-Current Liabilities data on file, last reported at -$31.6 million in Q4 2022.
- Quarterly Total Non-Current Liabilities rose 3.0% year-over-year to -$31.6 million in Q4 2022, while the trailing twelve-month figure through Dec 2022 was -$31.6 million (up 3.0% YoY) and the FY2022 annual result came in at -$31.6 million, up 3.0% from the prior year.
- Total Non-Current Liabilities improved to -$31.6 million in Q4 2022 per ZCMD's latest filing, from -$32.6 million in the prior quarter.
- Across five years, Total Non-Current Liabilities topped out at -$31.6 million in Q4 2022 and bottomed at -$32.6 million in Q4 2021.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 30.85 Bn | 24.28 Bn | 622.47 Mn | 1.72 Bn |
| 2 | BrightSpring Health Services | 12.29 Bn | 11.41 Bn | 482.22 Mn | 4.20 Bn |
| 3 | Healthequity | 7.80 Bn | 7.48 Bn | 256.31 Mn | 1.12 Bn |
| 4 | Hinge Health | 4.82 Bn | 4.51 Bn | 154.23 Mn | - |
| 5 | Doximity | 4.21 Bn | 3.46 Bn | 125.97 Mn | 172.85 Mn |
| 6 | Waystar Holding | 4.18 Bn | 4.03 Bn | 268.04 Mn | 1.90 Bn |
| 7 | 10x Genomics | 3.78 Bn | 3.24 Bn | 106.18 Mn | 200.21 Mn |
| 8 | Privia Health | 2.65 Bn | 2.28 Bn | 595.71 Mn | 10.69 Mn |
| 9 | Omnicell | 1.95 Bn | 1.78 Bn | 140.36 Mn | 737.31 Mn |
| 10 | Zhongchao | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | -31.59 Mn |
| Dec 31, 2021 | -32.57 Mn |